LOS ANGELES CAPITAL MANAGEMENT LLC - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2014$348,000
-12.1%
41,917
-10.6%
0.00%0.0%
Q4 2013$396,000
+4.2%
46,862
-1.6%
0.00%
-20.0%
Q3 2013$380,000
+5.6%
47,622
+2.0%
0.01%0.0%
Q2 2013$360,000–46,692–0.01%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders